In Vivo Pharmacologist- Immunology at Eli Lilly and Company

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Ph.D. in physiology, immunology, biology, pharmacology, or a closely related field
1-2 years' experience with in-vivo capabilities and human CD34+ hematopoietic stem cell engraftment
Strong/extensive in vivo capabilities
Skilled in human CD34+ hematopoietic stem cell engraftment into mice and execution of downstream studies
Proficient in cell isolation, cell culture, and immune cell differentiation procedures
Knowledgeable with ex vivo sample assays and analyses (e.g. ELISA, RNA isolation, Nanostring)
Familiarity with FACS and immunophenotyping
Ability to prioritize activities across multiple projects independently and effectively while demonstrating initiative and appropriate risk taking
Excellent communication and organizational skills to present findings in internal and external forums
Strong interpersonal skills and ability to excel in a highly collaborative environment
Strong experience with immunophenotyping, in vivo assay development, and interpretation of preclinical data

Responsibilities

Provide strong scientific and technical leadership to establish and innovate in in vivo models to interrogate mechanisms and pathways relevant to the discovery of novel treatments for autoimmune diseases and related pathologies
Be hands-on in the laboratory to leverage and develop in vivo and in vitro systems to generate critical data supporting new and existing programs
Function independently, work within a team-oriented lab environment and communicate results to cross functional discipline teams
Provide supervision and mentoring to 1-2 scientists, performance evaluations, and career development
Requirement for accurate record keeping, independent data analysis, and reporting of data in written and oral formats
Perform work in full compliance with Lilly Research Policies and complete all required training activities in the timeframe specified

Skills

In Vivo Models

Immunology

Humanized Mouse Systems

CD34+ Hematopoietic Stem Cell Engraftment

Immunophenotyping

In Vivo Assay Development

Preclinical Data Analysis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free